Holen Sie sich die Stockscreener-App
26.31
7.13%
-2.1501
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
40.12%
80.14
|
57.19 | 48.91 | 49.80 | 37.34 |
| Operating Income/Loss |
40.12%
-80.14
|
-57.19 | -48.91 | -49.80 | -37.34 |
| Nonoperating Income/Loss |
34.36%
3.61
|
5.50 | 5.49 | 3.169 | 3.635 |
| Income/Loss From Continuing Operations Before Tax |
48.05%
-76.53
|
-51.69 | -43.42 | -46.63 | -33.71 |
| Income/Loss From Continuing Operations After Tax |
48.05%
-76.53
|
-51.69 | -43.42 | -46.63 | -33.71 |
|
Net Income/Loss
|
48.05%
-76.53
|
-51.69 | -43.42 | -46.63 | -33.71 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.18%
63.79
|
63.67 | 1.7888 | 54.90 | 54.73 |
| Diluted Average Shares |
0.18%
63.79
|
63.67 | 1.7888 | 54.90 | 54.73 |
| Basic Earnings Per Share |
48.15%
-1.20
|
-0.81 | -0.72 | -0.85 | -0.62 |
| Diluted Earnings Per Share |
48.15%
-1.20
|
-0.81 | -0.72 | -0.85 | -0.62 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.68%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):